(Q46203748)

English

Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder (English)

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

0 references

obsessive-compulsive disorder

1 reference

based on heuristic

inferred from title

author name string

Bergqvist PB

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

Bouchard C

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

Blier P

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

Biological Psychiatry

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

45

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

164-174

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

A functional response to D1 dopamine receptor stimulation in the central nervous system: inhibition of the release of [3H]-serotonin from the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Effect of repeated electroconvulsive shocks on serotonergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Functional characterization of a 5-HT3 receptor which modulates the release of 5-HT in the guinea-pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

A comparison of phenelzine and imipramine in an obsessive-compulsive patient

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

MAOI for obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Regulation of striatal serotonin release by the lateral habenula-dorsal raphe pathway in the rat as demonstrated by in vivo microdialysis: role of excitatory amino acids and GABA

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Serotonin autoreceptor subsensitivity and antidepressant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Cerebral glucose metabolic rates in obsessive compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Desensitization of the neuronal 5-HT carrier following its long-term blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Response of phobic disorders with obsessive symptoms to MAO inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Differential effect of NMDA on extracellular serotonin in rat midbrain raphe and forebrain sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Opioid receptor regulation of 5-hydroxytryptamine release from the rat hippocampus measured by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

The pathogenesis and treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine D2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-3223(98)00154-1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/9951563

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46203748&oldid=2118851706"